Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

MCSE vs ACCL: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

ACCL Wins Head-to-Head Institutional Verdict (5–0 across 6 Pillars · 7–2 Matrix Metrics)

ACCL Overall Winner 6-Pillar Tally: MCSE 0 – 5 ACCL (1 Tie) Matrix Metrics: MCSE 2 – 7 ACCL

As of Nov 16, 2026, ACCL (ACCL) is the stronger overall head-to-head candidate over Franklin Templeton ETF Trust Franklin Sustainable International Equity ETF (MCSE) in the Tradestie Institutional Equity Comparison Engine, winning 7–2 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). MCSE carries a Unified Composite Score of 53.9/100 (HOLD) at $13.82 (N/M Forward P/E, N/A operating margin), whereas ACCL carries 64.2/100 (BUY) at $2.36 (N/M Forward P/E, 4.5% operating margin).

  • Technical & Structure Timing Caution: MCSE is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 46.4); meanwhile ACCL is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 39.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About MCSE vs ACCL
MCSE NASDAQ
Franklin Templeton ETF Trust Franklin Sustainable International Equity ETF
Institutional Equity
$13.82
-0.07% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.87β · 18% Vol
Unified Composite Score
53.9 / 100 HOLD
Tech 45.0 Fund 44.0 Flow 50.0 Mom 35.0
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -1.6%) with fading momentum, RSI 46
RSI-14: 46.4 · SMA20: $13.93 · SMA50: $14.06
ACCL US Equity Head-to-Head Winner
ACCL
Institutional Equity
$2.36
-0.84% 1D
Market Cap $33.2M
TTM Revenue $5.2M
Forward P/E N/M
Beta / 30D Vol -0.20β · 60% Vol
Unified Composite Score
64.2 / 100 BUY
Tech 70.0 Fund 59.0 Flow 50.0 Mom 70.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -4.9%), weak momentum, RSI 39
RSI-14: 39.2 · SMA20: $2.54 · SMA50: $2.65

6-Pillar Scorecard Institutional Category Breakdown (MCSE 0 – 5 ACCL)

Columns: Metric · MCSE · ACCL
1. Valuation Multiples ACCL
Forward P/E N/M N/M
Trailing P/E N/M 119.0x
PEG Ratio N/M N/M
EV / Revenue N/M 6.4x
2. Growth & Scale ACCL
Revenue Growth (YoY) N/A +11.3%
Earnings Growth (YoY) N/A -62.5%
TTM Revenue (USD) N/A $5.2M
Market Cap N/A $33.2M
3. Profitability & Quality ACCL
Gross Margin N/A 42.4%
Operating Margin N/A 4.5%
Net Profit Margin N/A 5.5%
Return on Equity (ROE) N/A 7.0%
4. Balance Sheet & Cash Flow ACCL
Cash Generation (TTM) N/A $245,425 EBITDA
Cash Flow Margin N/A 4.7% EBITDA Mgn
Net Cash / Leverage N/A ROE $0.43 Book/Sh · 7.0% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Distribution NEUTRAL · Markdown
6. R&D & Supply-Chain Moat ACCL
OpEx & R&D Intensity N/A 37.9% of Rev ($2.0M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Consulting Services Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: MCSE (2) vs ACCL (7)
Institutional Metric MCSE ACCL Criterion Row Edge
Market Capitalization
Scale
N/A $33.2M Larger Scale ACCL
Trailing P/E Ratio
Valuation
N/M 119.0x Lower Multiple ACCL
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
N/A +11.3% Higher Growth ACCL
Operating Margin (TTM)
Profitability
N/A 4.5% Higher Margin ACCL
Net Profit Margin
Profitability
N/A 5.5% Higher Margin ACCL
Return on Equity (ROE)
Capital Efficiency
N/A 7.0% Higher ROE ACCL
52-Week Range Position
Momentum
63% ($12–$15) 30% ($1–$5) Stronger Trend MCSE
Beta / 30D Volatility
Risk Regime
0.87β · 18% Vol -0.20β · 60% Vol Lower Realized Risk MCSE
Unified Institutional Score
Composite Signal
53.9 / 100 (HOLD) 64.2 / 100 (BUY) Higher Composite ACCL
Trailing 12M Revenue (USD)
Operating Scale
N/A $5.2M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A 42.4% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · 6.4x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) $245,425 EBITDA ($0.43 Book/Sh · 7.0% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon MCSE +29.09 pp
MCSE: +2.22% · ACCL: -26.87%
3M Horizon MCSE +20.98 pp
MCSE: -2.68% · ACCL: -23.66%
6M Horizon MCSE +20.98 pp
MCSE: -2.68% · ACCL: -23.66%
1Y Horizon MCSE +20.98 pp
MCSE: -2.68% · ACCL: -23.66%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MCSE vs ACCL. Trailing 12-month operating profitability (MCSE N/A vs ACCL 4.5%) and valuation multiples (MCSE N/M vs ACCL N/M Forward P/E) are benchmarked directly in Pillar 4 below.

MCSE ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
ACCL ADR TTM Benchmark FX-Normalized USD
TTM Revenue$5.2M
Gross Margin42.4%
Op. Margin4.5%
ROE / Fwd P/E7.0% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
MCSE UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact MCSE Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
ACCL UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact ACCL Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
MCSE Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
ACCL Moat Profile Cyclical / Execution-Driven Positioning
Consulting Services Operator
Competes within the Consulting Services value chain with $33.2M market capitalization and 4.5% operating margin.
OpEx & R&D Reinvestment 37.9% of Rev ($2.0M)
90D Engineering Disclosures 0 Published

Investor FAQ MCSE vs ACCL Key Questions & Quantitative Answers

As of Nov 16, 2026, ACCL (ACCL) is the stronger overall head-to-head candidate over Franklin Templeton ETF Trust Franklin Sustainable International Equity ETF (MCSE) in the Tradestie Institutional Equity Comparison Engine, winning 7–2 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). MCSE carries a Unified Composite Score of 53.9/100 (HOLD) at $13.82 (N/M Forward P/E, N/A operating margin), whereas ACCL carries 64.2/100 (BUY) at $2.36 (N/M Forward P/E, 4.5% operating margin). Technical & Structure Timing Caution: MCSE is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 46.4); meanwhile ACCL is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 39.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

ACCL leads the Growth & Scale pillar: MCSE posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with ACCL at +11.3% YoY revenue growth and -62.5% YoY earnings growth on $5.2M TTM revenue (42.4% gross margin, 4.5% operating margin). On trailing 12-month operating scale, MCSE generates N/A in USD-normalized revenue versus $5.2M for ACCL. In operating R&D and SG&A reinvestment, MCSE deploys N/A (0 90-day corporate R&D disclosures) versus 37.9% of Rev ($2.0M) (0 disclosures) for ACCL.

ACCL screens cheaper on headline valuation multiples. MCSE trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas ACCL trades at N/M Forward P/E, 119.0x Trailing P/E, N/M PEG, and 6.4x EV/Revenue (4.7% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against MCSE (N/A ROE) versus ACCL (7.0% ROE) capital efficiency.

In options market volatility and institutional positioning, MCSE carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.87β · 18% Vol realized risk). By comparison, ACCL carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.20β · 60% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.